|
1
|
Brierley JD, Gospodarowicz MK and
Wittekind C: TNM Classification of Malignant Tumours. Wiley
Blackwell; Oxford: 2017
|
|
2
|
Ferrara N, Gerber HP and LeCouter J: The
biology of VEGF and its receptors. Nat Med. 9:669–676. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lohela M, Bry M, Tammela T and Alitalo K:
VEGFs and receptors involved in angiogenesis versus
lymphangiogenesis. Curr Opin Cell Biol. 21:154–165. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Matsuura M, Onimaru M, Yonemitsu Y, Suzuki
H, Nakano T, Ishibashi H, Shirasuna K and Sueishi K: Autocrine loop
between vascular endothelial growth factor (VEGF)-C and VEGF
receptor-3 positively regulates tumor-associated lymphangiogenesis
in oral squamoid cancer cells. Am J Pathol. 175:1709–1721. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Maeda T, Matsumura S, Hiranuma H, Jikko A,
Furukawa S, Ishida T and Fuchihata H: Expression of vascular
endothelial growth factor in human oral squamous cell carcinoma:
Its association with tumour progression and p53 gene status. J Clin
Pathol. 51:771–775. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Smith BD, Smith GL, Carter D, Sasaki CT
and Haffty BG: Prognostic significance of vascular endothelial
growth factor protein levels in oral and oropharyngeal squamous
cell carcinoma. J Clin Oncol. 18:2046–2052. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Shang ZJ, Li JR and Li ZB: Circulating
levels of vascular endothelial growth factor in patients with oral
squamous cell carcinoma. Int J Oral Maxillofac Surg. 31:495–498.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Johnstone S and Logan RM: The role of
vascular endothelial growth factor (VEGF) in oral dysplasia and
oral squamous cell carcinoma. Oral Oncol. 42:337–342. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Schimming R, Reusch P, Kuschnierz J and
Schmelzeisen R: Angiogenic factors in squamous cell carcinoma of
the oral cavity: Do they have prognostic relevance? J
Craniomaxillofac Surg. 32:176–181. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Shintani S, Li C, Ishikawa T, Mihara M,
Nakashiro K and Hamakawa H: Expression of vascular endothelial
growth factor A, B, C, and D in oral squamous cell carcinoma. Oral
Oncol. 40:13–20. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sugiura T, Inoue Y, Matsuki R, Ishii K,
Takahashi M, Abe M and Shirasuna K: VEGF-C and VEGF-D expression is
correlated with lymphatic vessel density and lymph node metastasis
in oral squamous cell carcinoma: Implications for use as a
prognostic marker. Int J Oncol. 34:673–680. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Suzuki H, Fukuyama R, Hasegawa Y, Tamaki
T, Nishio M, Nakashima T and Tatematsu M: Tumor thickness, depth of
invasion, and Bcl-2 expression are correlated with FDG-uptake in
oral squamous cell carcinomas. Oral Oncol. 45:891–897. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Seki S, Fujiwara M, Matsuura M, Fujita S,
Ikeda H, Asahina I and Ikeda T: Prediction of outcome of patients
with oral squamous cell carcinoma using vascular invasion and the
strongly positive expression of vascular endothelial growth
factors. Oral Oncol. 47:588–593. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kato Y, Fujita N, Kunita A, Sato S, Kaneko
M, Osawa M and Tsuruo T: Molecular identification of Aggrus/T1alpha
as a platelet aggregation-inducing factor expressed in colorectal
tumors. J Biol Chem. 278:51599–51605. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Toyoshima M, Nakajima M, Yamori T and
Tsuruo T: Purification and characterization of the
platelet-aggregating sialoglycoprotein gp44 expressed by highly
metastatic variant cells of mouse colon adenocarcinoma 26. Cancer
Res. 55:767–773. 1995.PubMed/NCBI
|
|
16
|
Yuan P, Temam S, El-Naggar A, Zhou X, Liu
DD, Lee JJ and Mao L: Overexpression of podoplanin in oral cancer
and its association with poor clinical outcome. Cancer.
107:563–569. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kreppel M, Drebber U, Wedemeyer I, Eich
HT, Backhaus T, Zöller JE and Scheer M: Podoplanin expression
predicts prognosis in patients with oral squamous cell carcinoma
treated with neoadjuvant radiochemotherapy. Oral Oncol. 47:873–878.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Bartuli FN, Luciani F, Caddeo F, Compagni
S, Piva P, Ottria L and Arcuri C: Podoplanin in the development and
progression of oral cavity cancer: A preliminary study. Oral
Implantol (Rome). 5:33–41. 2012.PubMed/NCBI
|
|
19
|
Funayama A, Cheng J, Maruyama S, Yamazaki
M, Kobayashi T, Syafriadi M, Kundu S, Shingaki S, Saito C and Saku
T: Enhanced expression of podoplanin in oral carcinomas in situ and
squamous cell carcinomas. Pathobiology. 78:171–180. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kawaguchi H, El-Naggar AK,
Papadimitrakopoulou V, Ren H, Fan YH, Feng L, Lee JJ, Kim E, Hong
WK, Lippman SM and Mao L: Podoplanin: A novel marker for oral
cancer risk in patients with oral premalignancy. J Clin Oncol.
26:354–360. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Seki S, Fujiwara M, Matsuura M, Fujita S,
Ikeda H, Umeda M, Asahina I and Ikeda T: Prognostic value of
podoplanin expression in oral squamous cell carcinoma-a regression
model auxiliary to UICC classification. Pathol Oncol Res.
20:521–528. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Bonapace L, Coissieux MM, Wyckoff J, Mertz
KD, Varga Z, Junt T and Bentires-Alj M: Cessation of CCL2
inhibition accelerates breast cancer metastasis by promoting
angiogenesis. Nature. 515:130–133. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Abbas AK, Lichtman AH and Pillai S:
Cellular and Molecular Immunology 7th edition. Elsevier;
Philadelphia: pp. 389–405. 2012
|
|
24
|
Neville BWN, Damm DD, Allen CM and Chi AC:
Oral and Maxillofacial Pathology (4th). 2016.
|
|
25
|
Jakobsson PA, Eneroth CM, Killander D,
Moberger G and Mårtensson B: Histologic classification and grading
of malignancy in carcinoma of the larynx. Acta Radiol Ther Phys
Biol. 12:1–8. 1973. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Akaike H: Information theory and an
extention of the maximum likelihood principle2nd International
Symposium on Information Theory. Petrov BN and Csaki F: Budapest:
1973
|
|
27
|
Ihaka R and Gentleman R: R: A language for
data analysis and graphics. J Comp Graph Stat. 5:299–314. 1996.
View Article : Google Scholar
|
|
28
|
Chatzistamou I, Rodriguez J, Jouffroy T,
Girod A, Point D, Sklavounou A, Kittas C, Sastre-Garau X and
Klijanienko J: Prognostic significance of tumor shape and stromal
chronic inflammatory infiltration in squamous cell carcinomas of
the oral tongue. J Oral Pathol Med. 39:667–671. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Halama N, Braun M, Kahlert C, Spille A,
Quack C, Rahbari N, Koch M, Weitz J, Kloor M, Zoernig I, et al:
Natural killer cells are scarce in colorectal carcinoma tissue
despite high levels of chemokines and cytokines. Clin Cancer Res.
17:678–689. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Turkseven MR and Oygür T: Evaluation of
natural killer cell defense in oral squamous cell carcinoma. Oral
Oncol. 46:e34–e37. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Katou F, Ohtani H, Watanabe Y, Nakayama T,
Yoshie O and Hashimoto K: Differing phenotypes between
intraepithelial and stromal lymphocytes in early-stage tongue
cancer. Cancer Res. 67:11195–11201. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Landskron G, De la Fuente M, Thuwajit P,
Thuwajit C and Hermoso MA: Chronic inflammation and cytokines in
the tumor microenvironment. J Immunol Res. 2014:1491852014.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Mukaida N, Sasaki S and Baba T: Chemokines
in cancer development and progression and their potential as
targeting molecules for cancer treatment. Mediators Inflamm.
2014:1703812014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Qian BZ, Li J, Zhang H, Kitamura T, Zhang
J, Campion LR, Kaiser EA, Snyder LA and Pollard JW: CCL2 recruits
inflammatory monocytes to facilitate breast-tumour metastasis.
Nature. 475:222–225. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Song G, Ren J, Stojadinovic A, Chen W,
Sahab Z, Fu SW and Man YG: Conjunction of tumor cells with
lymphocytes: Implications for tumor invasion and metastasis. Cancer
Epidemiol. 36:354–363. 2012. View Article : Google Scholar : PubMed/NCBI
|
